Coherus Biosciences reported $6.58M in Interest Expense on Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Expense On Debt Change
Aerie Pharmaceuticals AERI:US USD 1.65M 12K
ALKERMES ALKS:US USD 3.55M 1.18M
Alnylam Pharmaceuticals ALNY:US USD 41.08M 1.52M
Amgen AMGN:US USD 368M 40M
Baxter International BAX:US USD 109M 16M
Biogen BIIB:US USD 59.9M 5.9M
Biomarin Pharmaceutical BMRN:US USD 4.68M 820K
Bristol Myers Squibb BMY:US USD 299M 14M
Eli Lilly And LLY:US USD 81.5M 300K
Endo International Ordinary Shares ENDP:US USD 74.93M 65M
Fujifilm 4901:JP JPY 933M 63M
Gilead Sciences GILD:US USD 229M 13M
Ironwood Pharmaceuticals IRWD:US USD 1.52M 683K
JAZZ PHA JAZZ:US USD 83.74M 19.86M
Myriad Genetics MYGN:US USD 800K 200K
Pacira Pharmaceuticals PCRX:US USD 9.86M 1.02M
Pfizer PFE:US USD 311M 18M
Ptc Therapeutics PTCT:US USD 19.48M 2.8M
Regeneron Pharmaceuticals REGN:US USD 15.3M 2.2M
Revance Therapeutics RVNC:US USD 6.92M 3.04M
Sarepta Therapeutics SRPT:US USD 14.74M 1.29M
Teva Pharmaceutical TEVA:IT USD 230M 5M
Vertex Pharmaceuticals VRTX:US USD 13.7M 900K
Zoetis ZTS:US USD 53M 0